Sacyr, S.A. SCYR.MC
Composite 44/100; the shares have moved about 27% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Balance-sheet strength ranks 21/100 — a strong mark against it.
Income ranks 88/100 — a strong point in its favour. Valuation ranks 76/100 — a strong point in its favour. Momentum ranks 51/100 — a slight point in its favour.
Balance-sheet strength ranks 21/100 — a strong mark against it. Growth ranks 27/100 — a moderate mark against it. Quality ranks 35/100 — a moderate mark against it.
What the company does Sacyr, S.A. develops and operates infrastructure concessions globally, focusing on transportation, sanitation, water, and waste treatment. It also undertakes large-scale civil engineering and building projects, with operations spanning Europe, Latin America, and other regions.
Key financials Sacyr reports gross margins of 66.5% and operating margins of 20.8%, but net margins stand at just 2.1%. Revenue grew 5.4% year-over-year, while EPS declined -36.3%. The company carries significant leverage, with a Debt/Equity ratio of 4.16 and Net Debt/EBITDA of 5.61, alongside an interest coverage ratio of 1.94.
Stock health Momentum is mixed: the stock is down -7.63% from its 52-week high but up 35.16% over 12 months. The RSI(14) stands at 41.40, indicating neither overbought nor oversold conditions. The Sidereavia score places Sacyr in the average quality tier, with strong momentum (65.2) but weak strength (25.1).
Price vs fair value The stock trades at a **discount of 128.50%** to our fair-value estimate of 10.44 and a **discount of 12.91%** to the analyst 12-month target of 5.16. - H1 2026 revenue and EBITDA surged 9% (GuruFocus.com). - Forward P/E of 23.64 and EV/EBITDA of 8.40 suggest valuation support. - Dividend yield is 2.0% with a payout ratio of 76.4%.
Looking forward Analysts expect forward earnings growth to improve, with a PEG of 0.38 signaling potential undervaluation. However, high leverage and weak EPS growth (-36.3%) remain key risks. Execution on concessions and margin recovery will be critical for valuation re-rating.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.